How Long Do Penile Injections for ED Last?

Most penile injections for erectile dysfunction produce an erection lasting somewhere between 30 minutes and two hours, though the actual duration depends heavily on the specific medication used, the dose, and the underlying cause of ED. That range is wide because there is no single “penile injection” for ED. Several different drug formulations exist, each with a different pharmacological profile, and doctors adjust doses individually through a careful titration process. The shelf life of the medication itself is another meaning of “how long do they last” that matters practically, especially for compounded formulations that degrade over time.

The Medications and How Their Durations Differ

Three main injectable formulations are used for ED. Alprostadil (also called prostaglandin E1, or PGE1) is the only FDA-approved single-agent injection. Trimix combines three drugs: alprostadil, papaverine, and phentolamine. QuadMix adds a fourth agent, typically atropine. Each blend works by relaxing the smooth muscle inside the penis, allowing blood to flow in and stay trapped, but they do so through slightly different pathways, which affects how long the resulting erection lasts.

In a head-to-head comparison, alprostadil alone tends to produce erections that last longer than Trimix. One prospective study found that patients responding to alprostadil at 20 micrograms had erections averaging roughly 1.5 to 1.7 hours, while those responding to Trimix averaged about 0.9 to 1.0 hours.¹ That difference is statistically meaningful and clinically relevant. Men using Trimix often get a shorter but still functional window, while alprostadil users may have more time but also face a slightly higher chance of the erection lasting uncomfortably long.

QuadMix is generally reserved for men with severe ED who have not responded to other options. In a series of 60 patients with ED that had failed oral medications, all achieved tumescence sufficient for intercourse within about 10 minutes of injection, and nearly all experienced spontaneous detumescence after ejaculation.² The rapid onset is a shared feature across all these injections; the real variable is how long the erection persists afterward.

Why the Dose Matters So Much

Penile injections are not a fixed-dose treatment. Every man starts with a low dose, usually administered in a doctor’s office, and the dose is gradually increased until the erection is firm enough for intercourse but not so strong that it refuses to go down. This process, called dose titration, is the most important factor in determining how long the erection will last on any given occasion.

A large dose-response study of nearly 300 men found a clear relationship between higher alprostadil doses and stronger erectile responses. All tested doses outperformed placebo, but increasing from 2.5 to 20 micrograms produced progressively higher response rates.³ In a separate multi-site study of nearly 900 men undergoing in-office dose titration with alprostadil, about 58% achieved a functionally rigid erection lasting at least 20 minutes.⁴ That 20-minute benchmark was a clinical floor, not a ceiling; most men who responded had erections lasting considerably longer.

The dose that works for one person can be wildly different from what another person needs. In the same dose-response study, the minimum effective dose varied dramatically depending on the cause of ED. Men with psychogenic ED needed very little medication, while men with vascular disease often needed several times more.³ This is why the first injection is always done under medical supervision: nobody can predict the right dose from the outside.

How the Cause of Your ED Changes the Response

The underlying reason you have ED shapes both how well injections work and how long the erection lasts. Men whose ED follows prostate surgery (radical prostatectomy) are one of the largest user groups for penile injections, since the nerve damage from surgery often makes oral pills ineffective. Injection therapy is considered highly effective for this population.⁵ In one study of post-prostatectomy patients, about half were actively using injections, with a median of three attempts per month. Among those users, 98% reported being sexually active.⁶

However, post-prostatectomy patients also face a higher rate of erections lasting longer than intended. In that same study, about 28% reported erections that lasted longer than they wished at some point during treatment, and roughly 10% experienced actual priapism, meaning erections that would not resolve on their own.⁶ This is partly because nerve-damaged tissue can respond unpredictably to vasoactive drugs.

Men with diabetes, by contrast, tend to have vascular damage that makes their tissue less responsive. A large review of over 1,400 patients on injection therapy found that response rates were lower in diabetic patients and in those who had undergone pelvic radiation.⁷ A long-term study following diabetic men for up to 10 years on injection therapy found that doses needed to be regulated to produce an erection lasting about 30 minutes, suitable for penetration. Over time, these patients tended to shift from alprostadil alone to multi-drug mixtures as their disease progressed, suggesting that the tissue became harder to stimulate with a single agent.⁸

For men with spinal cord injuries, injection therapy is one of the primary treatment options. Early survey data showed that patients on injection therapy reported intercourse an average of about three times per month.⁹ This population uses injections somewhat differently because the disconnect between the brain and the penile nerves creates a unique pattern of response.

When the Erection Lasts Too Long

An erection that will not go away is the most talked-about risk of penile injections, and for good reason. Priapism, defined as an erection lasting four hours or more, is a medical emergency. Blood trapped in the penis without circulation becomes oxygen-starved, and if not treated promptly, the result can be permanent tissue damage and loss of erectile function.

The actual rate of priapism varies by study and population. In one single-institution review of 233 men using Trimix, 15 developed priapism either during the initial in-office test or during subsequent home use. The study found that men who developed priapism tended to have lower hemoglobin A1c levels (meaning better blood sugar control, and thus better vascular health), which may paradoxically mean their blood vessels were more responsive to the medication than expected.¹⁰ In other words, it is not always the sickest patients who get priapism; healthier vascular tissue can overreact to the drug.

If an erection persists beyond what is normal, the first-line response does not have to be dramatic. A multicenter study found that exercise alone (think climbing stairs, jogging in place) resolved a prolonged erection within 30 minutes in about 40% of cases. For those who did not respond to exercise, oral salbutamol brought the erection down in another 34% within an hour. Only the remaining quarter of patients needed aspiration or a phenylephrine injection to resolve the situation.¹¹

When medical intervention is needed, treatment involves injecting phenylephrine directly into the penis at doses of 100 to 200 micrograms, which constricts the blood vessels and deflates the erection. This can be repeated every five minutes up to a maximum of one milligram over an hour, with blood pressure monitoring throughout.¹² The standard advice is to seek medical attention if an erection lasts more than three to four hours. Waiting longer makes the outcome worse.

How Satisfying the Experience Actually Is

Duration in minutes is one thing. Whether the resulting sexual encounter feels satisfying is another, and the data on this is surprisingly good. In a six-month self-injection study of 683 men using alprostadil, participants reported being able to have sexual activity after 94% of injections, and both the men and their partners rated the activity as satisfactory after roughly 87% of injections.³ Those are high numbers for any ED treatment. In the large Trimix review, 89% of Trimix users were capable of having intercourse.⁷

Satisfaction, though, is not the same as long-term continuation. Post-prostatectomy patients offer a revealing look at the gap: at an eight-year follow-up, only about 44% of men reported being satisfied with injections, and just 24% were still using them. The most common reasons for stopping were general dislike of the process, pain at the injection site, and return of natural erections.¹³ In a broader survey of 720 men using injections for various ED causes, the overall dropout rate was 31% over about three years, but the reasons were instructive. Cost, discomfort with the concept of injecting the penis, lack of a partner, and spontaneous improvement in erections were the main drivers. Actual treatment failure was the primary reason for only about one in seven who quit.¹⁴

Changes Over Years of Use

A question many men have after learning about injection therapy is whether it keeps working over time or whether they will need increasing doses. The evidence suggests a mixed picture. In diabetic men followed for up to a decade, the number of injections used per year actually declined, from an average of 50 in the first year to about 22 in the tenth year. But the formulations shifted toward stronger multi-drug mixtures, indicating that the tissue became less responsive to single agents over time.⁸ Whether this reflects worsening of the underlying vascular disease, tissue changes from the injections themselves, or both is hard to untangle.

Prolonged use of injection therapy can contribute to corporal fibrosis, the buildup of scar tissue inside the erectile chambers. This is listed alongside priapism, penile trauma, and infected implants as a recognized cause of fibrosis that can complicate future treatment options, including the placement of a penile prosthesis.¹⁵ Fibrosis does not happen to everyone, but it is one reason clinicians encourage using the lowest effective dose and not injecting more frequently than recommended, typically no more than three times per week with at least 24 hours between injections.

Combining Injections with Other Treatments

Some men use injections alongside oral ED medications rather than as a complete replacement. Combination therapy, pairing a pill with an injection or an intraurethral suppository, has been shown to salvage results for men who do not respond well to either approach alone. This strategy has been particularly useful after prostate surgery, where early combination treatment may speed the return of natural erectile function and restore responsiveness to oral medications over time.¹⁶ In practice, a man might take a PDE5 inhibitor daily and add an injection before sexual activity, which can allow a lower injection dose and thus a more predictable duration.

How Long the Medication Itself Lasts Before It Goes Bad

The other meaning of “how long do they last” is shelf life, and this matters more than many patients realize. Trimix is a compounded medication, meaning it is mixed by a specialty pharmacy rather than manufactured in a factory. The most vulnerable ingredient is alprostadil, which breaks down faster than the other components.

A stability study found that at room temperature, Trimix lost about 8% of its alprostadil content in just five days. Refrigerated at standard fridge temperature, it lost roughly 6% in one month and 11% in two months. Frozen at standard freezer temperature, less than 5% of any component was lost over six months.¹⁷ Based on those findings, a frozen vial that passes sterility testing is good for about six months, and a refrigerated vial for about one month. Leaving the vial on the bathroom counter, even briefly, accelerates degradation. A separate study of a slightly different Trimix formulation confirmed that alprostadil was the limiting factor, with the preparation exceeding the 10% loss threshold after about 55 days in the refrigerator.¹⁸

The practical takeaway is straightforward: keep your vial frozen if you are not going to use it within a few weeks, thaw only what you need in the refrigerator, and return it to cold storage immediately after drawing your dose. A vial that has been sitting in a warm car or on a nightstand for hours may still look clear and colorless but could have lost enough active ingredient to change how long and how well it works. If an injection that previously worked well suddenly seems weaker, a degraded vial is one of the first things to suspect before assuming you need a higher dose.

Pain and What to Expect at the Injection Site

Pain is a consistent concern in patient surveys, ranking as the second or third most common reason men stop using injections across multiple studies. In post-prostatectomy patients, 21% who discontinued cited pain as the primary reason.⁶ In a separate long-term follow-up, 33% of men who stopped listed pain among their reasons for quitting.¹³ The pain can come from the needle itself, from the medication as it enters the tissue (alprostadil in particular can cause a burning sensation), or from both. The discomfort typically fades within a few minutes and is less than what most men expect before their first try. Using a fine-gauge needle, injecting slowly, and allowing the medication to warm slightly before injection all help. Some men find that switching from alprostadil-only formulations to Trimix reduces pain, since the lower concentration of alprostadil in the mixture produces less local irritation.

Penile nodules, small lumps of scar tissue at injection sites, can develop with repeated use. Rotating the injection site on both sides of the shaft reduces this risk. These nodules are usually painless and do not affect erectile function unless they progress to more significant fibrosis, which is uncommon with proper technique and site rotation.

1
PubMed Central. Evaluation of the sensitivity of different doses of vasoactive drugs in diagnosing erectile dysfunction in impotent patients: a prospective case-control study
2
International Journal of Clinical Urology. OuadMix Penile Injection: An Initial Urologists Experience
3
PubMed. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction
4
International Journal of Impotence Research. Axial penile rigidity as primary efficacy outcome during multi-institutional in-office dose titration clinical trials with alprostadil alfadex in patients with erectile dysfunction
5
PubMed Central. Advances in the Management of Post-Radical Prostatectomy Erectile Dysfunction: Treatment Strategies When PDE-5 Inhibitors Don’t Work
6
PubMed. Clinical outcomes of intracavernosal injection in postprostatectomy patients: a single-center experience
7
PubMed. A review of outcomes of an intracavernosal injection therapy programme
8
PubMed. Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction
9
Taylor & Francis Online (The Journal of Spinal Cord Medicine). Epidemiology of current treatment for sexual dysfunction in spinal cord injured men in the USA model spinal cord injury centers
10
Oxford Academic (The Journal of Sexual Medicine). (175) IDENTIFYING RISK FACTORS FOR PRIAPISM IN MEN USING TRIMIX INJECTIONS FOR ERECTILE DYSFUNCTION AFTER PELVIC SURGERY
11
PubMed Central. Noninvasive treatments for iatrogenic priapism: Do they really work? A prospective multicenter study
12
Advanced Emergency Nursing Journal. Management of Priapism in the Emergency Department
13
PubMed Central. Long-term satisfaction and predictors of use in patients using intracorporeal injections (ICI) for post-prostatectomy erectile dysfunction (PPED)
14
PubMed. The causes of patient dropout from penile self-injection therapy for impotence
15
PubMed. Strategies for penile prosthesis placement in Peyronie’s disease and corporal fibrosis
16
PubMed Central. Oral and non-oral combination therapy for erectile dysfunction
17
PubMed. Long-term stability of trimix: a three-drug injection used to treat erectile dysfunction
18
PubMed. Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction